Health Neuroscience Center
Columbia, Missouri, 65203, United States
Location status: Recruiting
NCT Number: NCT06347055
The purpose of the study is to examine the effects of continuous theta burst stimulation (cTBS) on different forms of cognitive control in adults who smoke cigarettes, and to determine if the location where cTBS is delivered may help smokers reduce or quit smoking. Participation in the study will take 3-weeks over 4 visits, with a total time commitment of approximately 12 hours.
Interested in participating?
Request Info18 year–60 year
All sexes
Interventional
Not applicable
Columbia, Missouri, 65203, United States
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Continuous theta burst rTMS
Other names: cTBS
Time frame: 1 hour after receiving cTBS
between-arm differences in neurocognitive task performance as measured by percent correct on an inhibitory control task and self reported craving on a regulation of craving task.
Time frame: 1 hour after receiving cTBS
between-arm differences in whole brain fMRI BOLD functional connectivity. Neural network connectivity will be characterized using rZ values.
Time frame: 24 hours following receipt of cTBS
Safety and tolerability of cTBS administered to each cortical location, as measured by self reported side effects on a review of symptoms questionnaire.
Contact information is provided by the study sponsor or research team.
University of Missouri-Columbia
Other
Neuronavigated Non-invasive Brain Stimulation for Nicotine Dependence.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07698470
Behavior, Chemically-Induced Disorders
Los Angeles, California, United States
View Trial DetailsNCT07145866
Behavior, Behavior, Addictive
Boston, Massachusetts, United States
View Trial DetailsNCT07568483
Behavior, Chemically-Induced Disorders
Zurich, Switzerland
View Trial DetailsNCT06077240
Behavior, Chemically-Induced Disorders
New Haven, Connecticut, United States
View Trial Details